Moxifloxacin Ophthalmic

282 interactions 387 cited references

Also sold as: Moxeza® Vigamox Vigamox®

About Moxifloxacin Ophthalmic

Moxifloxacin ophthalmic solution is a fluoroquinolone antibiotic used to treat bacterial eye infections like pink eye. Read the full Moxifloxacin Ophthalmic drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Levoketoconazole Mesoridazine Pimozide Piperaquine Saquinavir Sparfloxacin

12 Contraindicated 251 Major 19 Moderate

All (282) Contraindicated (12) Major (251) Moderate (19)

Major

Moxifloxacin Ophthalmic Ertugliflozin Steglatro Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Erythromycin Erythrocin Stearate Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Escitalopram Lexapro An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Etrasimod Velsipity Increased risk of transient reduction in heart rate, AV conduction, QT interval prolongation and an increased risk of torsade de p... Details Moxifloxacin Ophthalmic Exenatide Bydureon Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Famotidine Calmicid Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Felbamate Felbatol Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Fexinidazole An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Fingolimod Gilenya Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Flecainide Tambocor® Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Fluconazole Diflucan Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Fludrocortisone An increased risk of tendon rupture Details Moxifloxacin Ophthalmic Fluocortolone An increased risk of tendon rupture Details Moxifloxacin Ophthalmic Fluoxetine RECONCILE An increased risk of QT interval prolongation and an increased risk of torsades de pointes Details Moxifloxacin Ophthalmic Formoterol Perforomist Increased risk of QT interval prolongation and an increased risk of cardiovascular adverse effects Details Moxifloxacin Ophthalmic Foscarnet Foscavir Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Fosfomycin Contepo An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Fosphenytoin Cerebyx Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Fostemsavir Rukobia Increased risk of torsade de pointes Details Moxifloxacin Ophthalmic Galantamine Razadyne Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Gatifloxacin Zymaxid Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Gemifloxacin Factive Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Gepirone Exxua An increased risk of QT interval prolongation and cardiac arrhythmias Details Moxifloxacin Ophthalmic Gepotidacin Blujepa An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Givinostat Duvyzat Increased risk of QT interval prolongation and torsade de pointes Details Moxifloxacin Ophthalmic Glasdegib Daurismo Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Glimepiride Amaryl Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Glipizide Glucotrol Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Glyburide DiaBeta® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Moxifloxacin Ophthalmic Goserelin Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Granisetron Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Halofantrine Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Haloperidol Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Histrelin Supprelin Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Hydrocortisone Ala-Cort An increased risk of tendon rupture Details Moxifloxacin Ophthalmic Hydroquinidine Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Hydroxychloroquine Plaquenil An increased risk of seizures and an increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Hydroxyzine An increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Ibutilide Corvert Increased risk of QT interval prolongation Details Moxifloxacin Ophthalmic Iloperidone Fanapt Increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.